Literature DB >> 33479823

Blood transfusion rates in Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action)-a single-center experience.

Hailey W Gavigan1, Cara L Slagle2, Kelli A Krallman3, Brenda B Poindexter2, David K Hooper3, Stuart L Goldstein3.   

Abstract

BACKGROUND: Previous studies in non-critically ill hospitalized pediatric patients have shown that daily serum creatinine monitoring for the development of nephrotoxic medication-associated acute kidney injury decreases both the rate of high nephrotoxic medication exposure and associated acute kidney injury. Attempts to spread this successful screening program have been met with concerns that daily serum creatinine monitoring in critically ill neonates with high-risk nephrotoxic medication exposure would lead to iatrogenic anemia and an increase in blood transfusion requirements.
METHODS: We measured blood transfusion rates while implementing a system of daily serum creatinine monitoring in critically ill neonates at risk for high nephrotoxic medication-associated acute kidney injury.
RESULTS: There was no correlation between blood transfusion rates and serum creatinine monitoring rates.
CONCLUSIONS: We recommend that critically ill neonates identified as having high-risk nephrotoxic medication exposure undergo daily screening for the development of nephrotoxic medication-associated acute kidney injury.

Entities:  

Keywords:  Iatrogenic anemia; Neonatal acute kidney injury; Nephrotoxic medication; Nephrotoxic medication–associated acute kidney injury

Mesh:

Substances:

Year:  2021        PMID: 33479823     DOI: 10.1007/s00467-020-04917-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in the Neonatal Intensive Care Unit.

Authors:  Christine Stoops; Sadie Stone; Emily Evans; Lynn Dill; Traci Henderson; Russell Griffin; Stuart L Goldstein; Carl Coghill; David J Askenazi
Journal:  J Pediatr       Date:  2019-12       Impact factor: 4.406

2.  3-5 year longitudinal follow-up of pediatric patients after acute renal failure.

Authors:  D J Askenazi; D I Feig; N M Graham; S Hui-Stickle; S L Goldstein
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

3.  A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children.

Authors:  Stuart L Goldstein; Devesh Dahale; Eric S Kirkendall; Theresa Mottes; Heather Kaplan; Stephen Muething; David J Askenazi; Traci Henderson; Lynn Dill; Michael J G Somers; Jessica Kerr; Jennifer Gilarde; Joshua Zaritsky; Valerie Bica; Patrick D Brophy; Jason Misurac; Richard Hackbarth; Julia Steinke; Joann Mooney; Sara Ogrin; Vimal Chadha; Bradley Warady; Richard Ogden; Wendy Hoebing; Jordan Symons; Karyn Yonekawa; Shina Menon; Lisa Abrams; Scott Sutherland; Patricia Weng; Fang Zhang; Kathleen Walsh
Journal:  Kidney Int       Date:  2019-11-01       Impact factor: 10.612

4.  Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit.

Authors:  James Schneider; Robinder Khemani; Carl Grushkin; Robert Bart
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

5.  Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults.

Authors:  Ahmad Kaddourah; Rajit K Basu; Sean M Bagshaw; Stuart L Goldstein
Journal:  N Engl J Med       Date:  2016-11-18       Impact factor: 91.245

6.  Electronic health record identification of nephrotoxin exposure and associated acute kidney injury.

Authors:  Stuart L Goldstein; Eric Kirkendall; Hovi Nguyen; Joshua K Schaffzin; John Bucuvalas; Tracey Bracke; Michael Seid; Marshall Ashby; Natalie Foertmeyer; Lori Brunner; Anne Lesko; Cynthia Barclay; Carole Lannon; Stephen Muething
Journal:  Pediatrics       Date:  2013-08-12       Impact factor: 7.124

7.  A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.

Authors:  Stuart L Goldstein; Theresa Mottes; Kendria Simpson; Cynthia Barclay; Stephen Muething; David B Haslam; Eric S Kirkendall
Journal:  Kidney Int       Date:  2016-05-21       Impact factor: 10.612

8.  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates: Design of a Retrospective Cohort Study.

Authors:  Jennifer G Jetton; Ronnie Guillet; David J Askenazi; Lynn Dill; Judd Jacobs; Alison L Kent; David T Selewski; Carolyn L Abitbol; Fredrick J Kaskel; Maroun J Mhanna; Namasivayam Ambalavanan; Jennifer R Charlton
Journal:  Front Pediatr       Date:  2016-07-19       Impact factor: 3.418

9.  Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study.

Authors:  Jennifer G Jetton; Louis J Boohaker; Sidharth K Sethi; Sanjay Wazir; Smriti Rohatgi; Danielle E Soranno; Aftab S Chishti; Robert Woroniecki; Cherry Mammen; Jonathan R Swanson; Shanty Sridhar; Craig S Wong; Juan C Kupferman; Russell L Griffin; David J Askenazi
Journal:  Lancet Child Adolesc Health       Date:  2017-11

10.  Nephrotoxic medication exposure in very low birth weight infants.

Authors:  Erika T Rhone; J Bryan Carmody; Jonathan R Swanson; Jennifer R Charlton
Journal:  J Matern Fetal Neonatal Med       Date:  2013-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.